Loading clinical trials...
Loading clinical trials...
The purpose of this post-market study is to evaluate UFE agents for the treatment of symptomatic uterine fibroids, using Gel-Bead compared to four other commonly used embolic agents.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital Southampton NHS Foundation Trust
Collaborators
NCT07652775 · Mild Cognitive Impairment (MCI), Depressive Symptoms
NCT07565428 · Negative Symptoms of Schizophrenia
NCT07020572 · Depressive Symptoms
NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more
NCT07624448 · Autism, Intellectual Disabilities With Other Behavioral Symptoms, and more
Southampton University Hospital NHS Trust
Southampton, Hampshire
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions